LEADS BIOLABS-B(09887),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09887 LEADS BIOLABS-B

Not Yet Opened 07-22 16:08:03

66.050

+2.200

+3.45%

High68.900	Low63.250	Vol1.62M
Open63.250	D1 Closing63.850	Amplitude8.85%
Mkt Cap13.14B	Tradable Cap13.08B	Total Shares199.00M
T/O107.54M	T/O Rate0.82%	Tradable Shares198.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"LEADS BIOLABS-B","latestPrice":66.05,"timestamp":1784707683011,"preClose":63.85,"halted":0,"volume":1615500,"delay":0,"changeRate":0.03445575567736876,"floatShares":198000000,"shares":199000000,"eps":-1.4005177848875507,"marketStatus":"Not Yet Opened","change":2.2,"latestTime":"07-22 16:08:03","open":63.25,"high":68.9,"low":63.25,"amount":107537340,"amplitude":0.088489,"askPrice":66.05,"askSize":100,"bidPrice":65.95,"bidSize":1100,"shortable":3,"etf":0,"ttmEps":-1.3623218452997083,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784770200000},"marketStatusCode":0,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":63.85,"openAndCloseTimeList":[[1784683800000,1784692800000],[1784696400000,1784707200000]],"volumeRatio":1.146248,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09887","defaultTab":"news","newsList":[{"id":"1175511625","title":"LEADS BIOLABS-B Shares Surge Over 11%, Marking a 30% Gain in Three Days on ESMO Research News","url":"https://stock-news.laohu8.com/highlight/detail?id=1175511625","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175511625?lang=en_us&edition=fundamental","pubTime":"2026-07-15 14:32","pubTimestamp":1784097144,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) have surged by over 11% today, extending a rally that has seen the stock gain more than 30% over the past three trading sessions.As of the latest update, the stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","BK4588","BK4585","HK0000252160.HKD","09887","VXUS","HK0000500386.USD","HK0000252152.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156225075","title":"LEADS BIOLABS-B Shares Surge Over 15% as Key Drug Candidate LBL-024 Enters Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1156225075","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156225075?lang=en_us&edition=fundamental","pubTime":"2026-07-14 11:52","pubTimestamp":1784001137,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) surged more than 15% during the morning trading session.As of the latest update, the stock is up 6.39%, trading at HK$63.30 with a turnover of HK$167 million.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","BK1161","09887","HK0000500386.USD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651192431","title":"Leads Biolabs Says Six Studies Accepted for Presentation at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651192431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651192431?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:58","pubTimestamp":1783933130,"startTime":"0","endTime":"0","summary":"Leads Biolabs says six studies accepted for presentation at ESMO 2026Nanjing Leads Biolabs flagged a potential catalyst as it secured Late-Breaking Abstract status for ESMO 2026, with the full submiss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL2gtKVv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","BK1161","09887","HK0000252152.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140815382","title":"Leads Biolabs Highlights R&D Momentum with Six Abstracts Accepted by 2026 ESMO, Including Two Top-Tier Oral Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=1140815382","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140815382?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:43","pubTimestamp":1783932228,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs”, HK: 09887) reported that six of its latest oncology studies have been selected for presentation at the 2026 annual meeting of the European Society...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132253753","title":"LEADS BIOLABS-B Announces Multiple Research Presentations Selected for Prestigious 2026 ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1132253753","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132253753?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:40","pubTimestamp":1783932034,"startTime":"0","endTime":"0","summary":"The biopharmaceutical company LEADS BIOLABS-B (ASX: 09887) has announced that six of its latest research findings have been accepted for presentation at the 2026 European Society for Medical Oncology...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651194299","title":"Nanjing Leads Biolabs Says Six Clinical Studies Win Presentation Slots at 2026 ESMO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2651194299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651194299?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:37","pubTimestamp":1783931830,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs says six clinical studies win presentation slots at 2026 ESMO meetingNanjing Leads Biolabs outlined six studies accepted for presentation at the 2026 ESMO meeting in Madrid on Oc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL6cGTfx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000252160.HKD","09887","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143216016","title":"LEADS BIOLABS-B Surges Over 27% in Morning Session as Velixicon® Application Granted Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1143216016","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143216016?lang=en_us&edition=fundamental","pubTime":"2026-07-13 11:31","pubTimestamp":1783913508,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) surged more than 27% in the morning trading session. At the time of writing, the stock was up 27.40%, trading at HK$63.60 with a turnover of HK$202 million. On July...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000500386.USD","09887","HK0000252152.HKD","IPOS","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650619185","title":"Nanjing Leads Biolabs Co - Opamtistomig Bla for Advanced Ep-nec Granted Priority Review by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2650619185","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650619185?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","HK0000500386.USD","HK0000252152.HKD","09887","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650318595","title":"Nanjing Leads Biolabs Co Ltd: Actively Advancing Relevant Pre-launch Commercialization Preparations","url":"https://stock-news.laohu8.com/highlight/detail?id=2650318595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650318595?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252160.HKD","HK0000500386.USD","09887","HK0000252152.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185616","title":"Priority Review Granted to Pd-l1/4-1bb Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in Ep-nec","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185616","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650185616?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09887","HK0000500386.USD","BK1161","HK0000252152.HKD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650907770","title":"Nanjing Leads Biolabs' Cancer Drug Included in China Regulator's Priority Review List","url":"https://stock-news.laohu8.com/highlight/detail?id=2650907770","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650907770?lang=en_us&edition=fundamental","pubTime":"2026-07-10 15:08","pubTimestamp":1783667303,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs'  biologics license application for LBL-024 was approved for inclusion in priority review and approval procedure by China's National Medical Products Administration.The drug has been developed as monotherapy for the treatment of advanced extrapulmonary neuroendocrine carcinoma, according to a Friday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000252152.HKD","HK0000252160.HKD","09887","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114500368","title":"LEADS BIOLABS-B's Novel Cancer Therapy LBL-024 Granted Priority Review in China for Advanced Neuroendocrine Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1114500368","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114500368?lang=en_us&edition=fundamental","pubTime":"2026-07-10 12:34","pubTimestamp":1783658060,"startTime":"0","endTime":"0","summary":"The biologics license application for LEADS BIOLABS-B's (ASX: 09887) investigational drug, VELIXIN™ (the PD-L1/4-1BB bispecific antibody oplitelimab, LBL-024), as a monotherapy for advanced...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","BK4023","HK0000252160.HKD","PD","09887","LU1169589451.USD","BK1161","LU1169590202.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650901310","title":"Nanjing Leads Biolabs Says China Regulator Puts Lbl-024 Ep-nec Filing in Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2650901310","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650901310?lang=en_us&edition=fundamental","pubTime":"2026-07-10 12:28","pubTimestamp":1783657691,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs says China regulator puts LBL-024 EP-NEC filing in priority reviewNanjing Leads Biolabs’ China BLA for LBL-024 (opamtistomig) in advanced EP-NEC entered NMPA-CDE priority review.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL8LMSg9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000500386.USD","09887","HK0000252152.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189242408","title":"Leads Biolabs Converts 44.39 Million Unlisted Shares to H Shares, Lifting Outstanding H Shares to 197.67 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1189242408","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189242408?lang=en_us&edition=fundamental","pubTime":"2026-07-02 17:25","pubTimestamp":1782984351,"startTime":"0","endTime":"0","summary":"On 02 July 2026, Nanjing Leads Biolabs Co., Ltd. filed its Monthly Return for the period ended 30 June 2026 with Hong Kong Exchanges and Clearing Limited, detailing a sizeable realignment of its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183498438","title":"LEADS BIOLABS-B Awards 2.2547 Million Shares Under H-Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1183498438","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183498438?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:20","pubTimestamp":1782908424,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) has announced the granting of a total of 2.2547 million share awards under its H-share incentive scheme.The awards were granted to 149 recipients on July 1, 2026, and are subject to acceptance by the grantees to become effective.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000500386.USD","BK1161","HK0000252152.HKD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648051015","title":"Nanjing Leads Biolabs Grants 2,254,691 H-share Awards Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2648051015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648051015?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:45","pubTimestamp":1782906351,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs grants 2,254,691 H-share awards under employee incentive schemeNanjing Leads Biolabs granted 2,254,691 share Awards under its H Share Award Scheme, covering 149 employees.Executi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL8wPBMC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","09887","HK0000252152.HKD","HK0000252160.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647575581","title":"This Nanjing Leads Biolabs Insider Reduced Their Stake By 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647575581","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647575581?lang=en_us&edition=fundamental","pubTime":"2026-06-30 09:44","pubTimestamp":1782783864,"startTime":"0","endTime":"0","summary":"From what we can see, insiders were net sellers in Nanjing Leads Biolabs Co., Ltd.'s ( HKG:9887 ) during the past 12...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9887/nanjing-leads-biolabs-shares/news/this-nanjing-leads-biolabs-insider-reduced-their-stake-by-40","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9887/nanjing-leads-biolabs-shares/news/this-nanjing-leads-biolabs-insider-reduced-their-stake-by-40","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000252160.HKD","HK0000500386.USD","09887","HK0000252152.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119804571","title":"Assessing LEADS BIOLABS-B After a 50% Price Drop: H-Share Full Circulation, Early Shareholder Unlock, and Custody Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1119804571","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119804571?lang=en_us&edition=fundamental","pubTime":"2026-06-26 09:59","pubTimestamp":1782439157,"startTime":"0","endTime":"0","summary":"Since last September, the Hong Kong stock market's innovative drug sector has shifted from its previous bull market state, entering a volatile downtrend, with a particularly persistent decline...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK1161","09887","HK0000252152.HKD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107543120","title":"New Energy System Blueprint and Rural EV Initiative Unveiled as Key Stocks Report Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1107543120","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107543120?lang=en_us&edition=fundamental","pubTime":"2026-06-26 07:26","pubTimestamp":1782429979,"startTime":"0","endTime":"0","summary":"Two major national plans have been announced, focusing on the development of a new energy system by 2030 and a new round of rural new energy vehicle promotion. Key Developments The National...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","HK0000306701.USD","00020","BK4588","HK0000252160.HKD","BK1512","LU1675838814.USD","80020","BK1113","BK1589","03998","HK0000306685.HKD","09887","BK1613","BK1109","HK0000252152.HKD","BK1227","BK1161","BK1615","BK1574","BK1500","VXUS","LU1808992512.USD","09879","HK0000320223.HKD","HK0000500386.USD","BK1502","HK0000320264.USD","HK0000165453.HKD","02616","159945","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646874382","title":"Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-specific T-cell Engager Lbl‑051 for Autoimmune Diseases into Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2646874382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646874382?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:38","pubTimestamp":1782383880,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA2BPFC5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","HK0000500386.USD","HK0000252152.HKD","09887","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.leadsbiolabs.com","stockEarnings":[{"period":"1week","weight":-0.0697},{"period":"1month","weight":0.2569},{"period":"3month","weight":-0.193},{"period":"6month","weight":0.1784},{"period":"1year","weight":0.8871},{"period":"ytd","weight":0.2951}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0473},{"period":"3month","weight":-0.0395},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0094},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Nanjing Leads Biolabs Co Ltd is a China-based company primarily engaged in the discovery, development, and commercialization of new therapies in oncology, autoimmune, and other severe diseases. The Company’s main drug candidates include LBL-024, LBL-034, LBL-033, LBL-007 and others. The company's LBL-024 is mainly used to treat extra-pulmonary neuroendocrine carcinoma (EP-NEC), small cell lung cancer (SCLC), biliary tract carcinoma (BTC), non-small-cell lung cancer (NSCLC), esophageal squamous cell carcinoma (ESCC), hepatocellular carcinoma (HCC), gastric cancer (GC) and other solid tumors. The Company has also developed multiple proprietary technology platforms, including LeadsBod platform (a CD3 T-cell engager platform), X-body platform (a 4-1BB engager platform) and several other bispecific antibody and fusion protein platforms. The Company mainly conducts its business in the domestic market.","exchange":"SEHK","name":"LEADS BIOLABS-B","nameEN":"LEADS BIOLABS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LEADS BIOLABS-B(09887),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LEADS BIOLABS-B(09887) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LEADS BIOLABS-B,09887,LEADS BIOLABS-B股票,LEADS BIOLABS-B股票老虎,LEADS BIOLABS-B股票老虎国际,LEADS BIOLABS-B行情,LEADS BIOLABS-B股票行情,LEADS BIOLABS-B股价,LEADS BIOLABS-B股市,LEADS BIOLABS-B股票价格,LEADS BIOLABS-B股票交易,LEADS BIOLABS-B股票购买,LEADS BIOLABS-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LEADS BIOLABS-B(09887),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LEADS BIOLABS-B(09887) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}